Author:
Ayub Humaira,Azam Maleeha,Micheal Shazia,Imran Khan Muhammad,Akhtar Farah,Khor Chiea Chuen,Aung Tin,den Hollander Anneke,Qamar Raheel
Reference75 articles.
1. Faucher M, Anctil JL, Rodrigue MA, Duchesne A, Bergeron D, Blondeau P, Cote G, Dubois S, Bergeron J, Arseneault R, Morissette J, Raymond V. Founder TIGR/myocilin mutations for glaucoma in the Quebec population. Hum Mol Genet. 2002;11:2077–90.
2. Baird PN, Craig JE, Richardson AJ, Ring MA, Sim P, Stanwix S, Foote SJ, Mackey DA. Analysis of 15 primary open-angle glaucoma families from Australia identifies a founder effect for the Q368STOP mutation of myocilin. Hum Genet. 2003;112:110–6.
3. Pang CP, Leung YF, Fan B, Baum L, Tong WC, Lee WS, Chua JK, Fan DS, Liu Y, Lam DS. TIGR/MYOC gene sequence alterations in individuals with and without primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2002;43:3231–5.
4. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265:2037–48.
5. Alward WL, Fingert JH, Coote MA, Johnson AT, Lerner SF, Junqua D, Durcan FJ, Mccartney PJ, Mackey DA, Sheffield VC, Stone EM. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N Engl J Med. 1998;338:1022–7.